Articles From: Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results to Agnico Eagle provides notice of release of fourth quarter 2013 results and conference call


2014/3/6
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of cancer metabolism and inborn errors of metabolism, today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2013.
Sign-up for Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results investment picks
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of cancer metabolism and inborn errors of metabolism, today reported business highlights and financial results for the third quarter ended September 30, 2013.
Sign-up for Agios Pharmaceuticals Reports Third Quarter 2013 Financial Results investment picks
2014/2/6
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of cancer metabolism and inborn errors of metabolism, today announced that David Schenkein, M.D., chief executive officer, is scheduled to present at the 2014 Leerink Swann Global Healthcare Conference on Thursday, February 13, 2014 at 3:30 p.m. EST at the Waldorf Astoria Hotel in New York City.
Sign-up for Agios Pharmaceuticals to Present at the 2014 Leerink Swann Global Healthcare Conference investment picks
2014/1/6
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of cancer metabolism and inborn errors of metabolism, today announced that David Schenkein, M.D., chief executive officer, is scheduled to present at the 32 nd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2014 at 3:00p.m. PST in San Francisco.
Sign-up for Agios Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference investment picks
2014/2/24
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of cancer metabolism and inborn errors of metabolism, today announced that David Schenkein, M.D., chief executive officer, is scheduled to present at the Cowen and Company 34 th Annual Health Care Conference on Monday, March 3, 2014 at 2:50PM EST at the Boston Marriott Copley Place.
Sign-up for Agios Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference investment picks
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) , today announced that David Schenkein, M.D., chief executive officer, will present at the Morgan Stanley Global Healthcare conference on Wednesday, September 11, 2013 at 11:45 a.m. ET in New York City.
Sign-up for Agios Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference investment picks
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) , today announced that preclinical data from the company’s research in dysregulated metabolism will be featured in oral and poster presentations at the 12 th International Congress of Inborn Errors of Metabolism (ICIEM), taking place September 3-6, 2013 in Barcelona, Spain.
Sign-up for Agios Pharmaceuticals to Present New Research at the 12th International Congress of Inborn Errors of Metabolism investment picks
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), today announced that the company will present insights into its lead cancer metabolism and inborn errors of metabolism (IEM) programs at the 2013 American Society of Hematology (ASH) Annual Meeting, taking place December 7-10, 2013 in New Orleans.
Sign-up for Agios Pharmaceuticals to Present Preclinical Research at the 2013 American Society of Hematology Annual Meeting investment picks
2014/2/27
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of cancer metabolism and inborn errors of metabolism, today announced that the company will host a conference call and live audio webcast on Thursday, March 6, 2014, at 8:30 a.m. EST to report its fourth quarter and full year 2013 financial results and discuss recent business activities.
Sign-up for Agios Pharmaceuticals to Webcast Conference Call Discussing Fourth Quarter and Full Year 2013 Financial Results on March 6, 2014 investment picks
2013/10/31
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of cancer metabolism and inborn errors of metabolism, today announced that the company will host a conference call and live audio webcast on Thursday, November 7, 2013, at 8:30 a.m. EST to report its third quarter 2013 financial results and discuss recent business activities.
Sign-up for Agios Pharmaceuticals to Webcast Conference Call Discussing Third Quarter 2013 Financial Results on November 7, 2013 investment picks
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), today announced that the company will present insights into its lead isocitrate dehydrogenase (IDH) program at the at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place October 19-23, 2013 in Boston.
Sign-up for Agios to Present IDH Program Insights at AACR-NCI-EORTC International Conference investment picks
AgJunction Core Technology Center Stage at AGRITECHNICA 2013 with Introduction of New CLAAS Guidance Terminals Canada NewsWire CLAAS Agrosystems KGaA mbH & Co KG will showcase two new guidance control terminals during AGRITECHNICA 2013, both of which integrate key hardware and software technology developed by AgJunction.
Sign-up for AgJunction Core Technology Center Stage at AGRITECHNICA 2013 with Introduction of New CLAAS Guidance Terminals investment picks
AgJunction Delivers Q3 Profit Canada NewsWire HIAWATHA, KS , Nov.
Sign-up for AgJunction Delivers Q3 Profit investment picks
2014/3/18
AgJunction Grows 37% on Strong Q4 Revenue Canada NewsWire "International revenue jumps 160% in fourth quarter on OEM growth" HIAWATHA, KS , March 18, 2014 /CNW/ - (TSX: AJX ) -- AgJunction today reported a 37% increase in fourth quarter revenues compared to last year driven by strong OEM growth.
Sign-up for AgJunction Grows 37% on Strong Q4 Revenue investment picks
AgJunction Q3 2013 Conference Call Notice Canada NewsWire HIAWATHA, KS , Oct.
Sign-up for AgJunction Q3 2013 Conference Call Notice investment picks
2014/2/26
AgJunction Q4 2013 Conference Call Notice Canada NewsWire HIAWATHA, KS , Feb.
Sign-up for AgJunction Q4 2013 Conference Call Notice investment picks
AgJunction Reports 2013 Q2 Results Canada NewsWire HIAWATHA, KS , Aug.
Sign-up for AgJunction Reports 2013 Q2 Results investment picks
2014/3/18
AgJunction® Rounds Out ISOBUS Offering with New Outback MAX™ Release Featuring Advanced Task Controller and Built-in WIFI Connectivity Canada NewsWire Last Fall AgJunction announced the addition of the Virtual Terminal feature for Outback MAX to support ISOBUS implement control.
Sign-up for AgJunction® Rounds Out ISOBUS Offering with New Outback MAX™ Release Featuring Advanced Task Controller and Built-in WIFI Connectivity investment picks
2014/2/5
By Ross Kelly SYDNEY--AGL Energy Ltd.
Sign-up for AGL Bid For Australian Power Assets Sparks Regulator Concerns investment picks
SYDNEY--AGL Energy Ltd.
Sign-up for AGL Bids $1.37 Billion for Macquarie Generation investment picks
2014/2/11
By Ross Kelly SYDNEY--AGL Energy Ltd.
Sign-up for AGL Energy Bids A$1.51 Billion for Macquarie Generation investment picks
By David Rogers SYDNEY--Australia's AGL Energy Ltd.
Sign-up for AGL Energy Says Warm Weather to Curb Profit investment picks
By Ross Kelly SYDNEY--Electricity retailer AGL Energy Ltd.
Sign-up for AGL Optimistic on A$1.51 Billion Power Deal investment picks
Agnico Eagle announces development project update - La India commissioning underway and mining and processing has restarted at Goldex Canada NewsWire Stock Symbol: AEM (NYSE and TSX) (All amounts expressed in U.S. dollars unless otherwise noted) TORONTO , Sept.
Sign-up for Agnico Eagle announces development project update - La India commissioning underway and mining and processing has restarted at Goldex investment picks
2013/9/19
Stock Symbol: AEM (NYSE and TSX) (All amounts expressed in U.S. dollars unless otherwise noted) TORONTO , Sept.
Sign-up for Agnico Eagle announces development project update - La India commissioning underway and mining and processing has restarted at Goldex investment picks
(All amounts expressed in Canadian dollars) Stock Symbol:      AEM (NYSE and TSX) TORONTO , Dec.
Sign-up for Agnico Eagle announces investment in Pershimco Resources Inc. investment picks
2013/12/20
Agnico Eagle announces investment in Pershimco Resources Inc. Canada NewsWire (All amounts expressed in Canadian dollars) Stock Symbol:      AEM (NYSE and TSX) TORONTO , Dec.
Sign-up for Agnico Eagle announces investment in Pershimco Resources Inc. investment picks
2014/4/1
Agnico Eagle provides notice of release of first quarter 2014 results, conference call and Annual General Meeting Canada NewsWire TORONTO , April 1, 2014 /CNW/ - Agnico Eagle Mines Limited (NYSE: AEM) (TSX: AEM) ("Agnico Eagle" or the "Company") today announced that it will release its first quarter 2014 results on Thursday, May 1, 2014 , after normal trading hours.
Sign-up for Agnico Eagle provides notice of release of first quarter 2014 results, conference call and Annual General Meeting investment picks
2014/4/1
TORONTO , April 1, 2014 /PRNewswire/ - Agnico Eagle Mines Limited (NYSE: AEM) (TSX: AEM) ("Agnico Eagle" or the "Company") today announced that it will release its first quarter 2014 results on Thursday, May 1, 2014 , after normal trading hours.
Sign-up for Agnico Eagle provides notice of release of first quarter 2014 results, conference call and Annual General Meeting investment picks
Agnico Eagle provides notice of release of fourth quarter 2013 results and conference call Canada NewsWire TORONTO , Jan.
Sign-up for Agnico Eagle provides notice of release of fourth quarter 2013 results and conference call investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results to Agnico Eagle provides notice of release of fourth quarter 2013 results and conference call
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity